aptaTargets (@AptaTargets) header
aptaTargets (@AptaTargets) profile picture

Pioneering therapies based on #aptamer technology

Madrid (Spain)
Joined January 2022
Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)Photo by aptaTargets (@AptaTargets)
We are excited to announce an agreement with @MerckHealthcare for the clinical development and commercialization of #ApTOLL, a Toll-like receptor 4 (TLR4) antagonist being developed for acute ischemic stroke. Learn more: aptatargets.com/newsroom/apt… #healthcare #innovation
5
2
14
916
🌟 aptaTargets and @merckgroup named finalists in 2025 European @lifestarsawards for transfer of neuroprotective drug #ApTOLL 🌟 Learn more on our website: aptatargets.com/newsroom/apt… #lifestarsawards
1
103
#ApTOLL’s secondary analysis data of APRIL 1b/2a trial published in scientific journal “Stroke” from @American_Heart: aptatargets.com/newsroom/apt… #stroke #AcuteIschemicStroke #cerebroprotection
2
5
109
#Investigación | ➡️El emprendimiento en el ámbito biomédico va acompañado de algunas metas a superar específicas de este sector. ➡David Segarra, CEO de @AptaTargets, cuenta los obstáculos a superar en el escalado de la innovación en este sector. diariomedico.com/medicina/in…
1
2
502
#Investigación | ➡️El emprendimiento en el ámbito biomédico va acompañado de algunas metas a superar específicas de este sector. ➡David Segarra, CEO de @AptaTargets, cuenta los obstáculos a superar en el escalado de la innovación en este sector. diariomedico.com/medicina/in…
1
2
176
.@inveready has achieved a 4x return on its Innvierte Biotech II fund. Benchmark Spanish financial newspaper @expansioncom highlights aptaTargets among its top investments. aptaTargets recently transferred its drug #ApTOLL to @merckgroup.
1
2
67
#Industria | aptaTargets transfiere ApTOLL a Merck 📰 tinyurl.com/yv9dsuap @AptaTargets @merck_es
1
1
5
111
⚕️Today on #WorldHealthDay, we're highlighting three top #eicBAS beneficiaries driving better #HealthForAll and #HopefulFutures globally: 💡 @SymphysisMed 🧠 @AptaTargets 🩺 Better Medicine Check them out 👉 tinyurl.com/yntdfexc
4
3
1
8
622
A new study shows the cerebroprotective effects of #ApTOLL on mice with #AcuteIschemicStroke: bit.ly/3yR1ZAX The study, published in "Pharmaceutics" (@MDPIpharma), was conducted by researchers at aptaTargets (Dr. Macarena Hernández) and @IISLaFe (Dr. Juan Salom).
1
5
445
Preclinical studies validate the potential of #ApTOLL developed by aptaTargets to reduce inflammation and regenerate myelin in models of #MultipleSclerosis. Results published in @BrJPharmacol: bit.ly/3WPkbF4
4
5
334
Today our Clinical Operations Manager @MarcoPugliese7 will speak at "Creative strategies to accelerate patient recruitment rate during study planning" in Barcelona. With Alicia Rami @Fortrea, @Estrell67715016 (Almirall), Núria Bordas @ferrerforgood and Joseph Lovett @Medidata 👇🏼
1
2
270
There's still time to register for #ESOC2024 in Basel, starting in just a week! 📅 ow.ly/7im650RuF4V Get ready to hear from leading experts, engage in innovative discussions, and be part of the latest advancements in stroke research. #stroke #voiceofstroke #stroketwitter
6
18
1,983
Our CSO Macarena Hernández (@makimhj) will speak at the 10th European #Stroke Conference next May 15 in Basel. Join us to discover “Tackling the Inflammation: The #APRIL group”. 🕓 3:50 pm 📍 Basel - Room Boston ℹ️ bit.ly/44tCnpm #ESOC2024 #ApTOLL #cytoprotection
3
6
208
We are thrilled to announce that over 1,000 companies in Europe, aptaTargets was selected for the #EICAccelerator by @EUeic. It secures €2.5M grant to start the Phase 2b clinical trial with #ApTOLL in patients with #AcuteIschemicStroke: bit.ly/3v5tg0O
1
3
450
aptaTargets retweeted
Proximo miercoles en el @USPCEU hablaré sobre los #aptameros y sus aplicaciones. Desde @AptaTargets trabajamos en el consorcio @oligofastx en el tratamiento de #EnfermedadesRaras como el Síndrome de Guillain-Barré
2
3
118
El próximo miércoles 6 de marzo recibiremos a Miguel Moreno Molina, de @AptaTargets, en nuestros seminarios de la @USPCEU . Conoceremos los últimos avances en tecnología de aptámeros. Bienvenido!
1
1
3
111
aptaTargets, that has obtained the Seal of Excellence 🏅 from the #EICAccelerator, has been selected by the @ComunidadMadrid to receive a direct grant of €1.940M: bit.ly/3UJI4N0 #ApTOLL #neuroprotection #AcuteIschemicStroke #EUeic #HorizonEurope #NextGenerationEU
5
85
aptaTargets retweeted
🧪 #OLIGOFASTX has the leading experts in each field in the area of oligonucleotide research who can provide solutions in the research of new therapies against rare diseases. 🧬 📌 oligofastx.com/ #fundedbyCDTI
1
1
58